Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit B1 pseudogene 1 (NDUFB1P1)

Target
NDUFB1P1
Molecular classification
Other (Pseudogene)
01

Overview

NDUFB1P1 (NADH:ubiquinone oxidoreductase subunit B1 pseudogene 1) is a pseudogene related to the NDUFB1 gene, which encodes a subunit of mitochondrial Complex I (NADH dehydrogenase [ubiquinone]). Pseudogenes are genomic DNA sequences similar to normal genes but typically contain mutations that prevent them from encoding functional proteins. NDUFB1P1 does not give rise to a functional protein and does not have an identified physiological or pathological role. It is distinct from the functional NDUFB1 protein, an accessory subunit of the respiratory chain involved in mitochondrial electron transport[2]. Key clarification: If you are seeking information on the functional subunit of Complex I, refer to the NDUFB1 gene/protein: "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1" (NDUFB1)[2]. The pseudogene (NDUFB1P1) should not be used as a therapeutic target entry.

Other names
bcm3095NDUFB1P1NADH:ubiquinone oxidoreductase subunit B1 pseudogene 1
02

Mechanism of action

None (not a drug target)

03

Biological functions

None (as a pseudogene, NDUFB1P1 does not have a biological function or established role in physiological processes)
04

Disease associations

None known (pseudogenes generally have no direct causal role in disease, though some may act as non-coding RNAs in rare regulatory contexts; there is no evidence for such a function for NDUFB1P1)
05

Safety considerations

None
06

Interacting drugs

None (there are no drugs that target this pseudogene)
07

Biomarkers

None

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit B1 pseudogene 1 (NDUFB1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B1 pseudogene 1 (NDUFB1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call